相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression
Darshan S. Chandrashekar et al.
ONCOGENE (2020)
Structure, Function, and Regulation of the SRMS Tyrosine Kinase
Chakia J. McClendon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PSPC1: a contextual determinant of tumor progression
Yaw-Dong Lang et al.
MOLECULAR & CELLULAR ONCOLOGY (2020)
Vemurafenib Inhibits Active PTK6 in PTEN-null Prostate Tumor Cells
Darren J. Wozniak et al.
MOLECULAR CANCER THERAPEUTICS (2019)
MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells
Patrice Cagle et al.
SCIENTIFIC REPORTS (2019)
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
Sayem Miah et al.
BMC CANCER (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression
Yaw-Dong Lang et al.
NATURE COMMUNICATIONS (2019)
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
Cecilie Bucher-Johannessen et al.
CLINICAL EPIGENETICS (2019)
Clustal Omega for making accurate alignments of many protein sequences
Fabian Sievers et al.
PROTEIN SCIENCE (2018)
Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma
Di Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Priyank Patel et al.
MOLECULAR CANCER RESEARCH (2018)
Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis
Tarah M. Regan Anderson et al.
MOLECULAR CANCER RESEARCH (2018)
Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers
Luping Qiu et al.
PLOS ONE (2018)
Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin (vol 1, pg 1, 2018)
Chao Tang et al.
ISCIENCE (2018)
Ensembl variation resources
Sarah E. Hunt et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2018)
Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors
Jie Jiang et al.
CANCER RESEARCH (2017)
Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters
Yuichi Abe et al.
JOURNAL OF PROTEOME RESEARCH (2017)
PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and Migration Through Phosphorylation of Eps8
Won-Sik Shin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Overexpression of miR-214 promotes the progression of human osteosarcoma by regulating the Wnt/β-catenin signaling pathway
Xun-Bing Zhu et al.
MOLECULAR MEDICINE REPORTS (2017)
The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation
Hyun Jae Shim et al.
ONCOLOGY LETTERS (2017)
PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
Darren J. Wozniak et al.
NATURE COMMUNICATIONS (2017)
Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
Xue-lian Xu et al.
JOURNAL OF CANCER (2017)
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells
Koichi Ito et al.
NPJ BREAST CANCER (2017)
Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution
Manish Kumar Thakur et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution
Manish Kumar Thakur et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer
Feifei Zhang et al.
CANCER LETTERS (2016)
PTK6 Inhibition Suppresses Metastases of Triple-Negative Breast Cancer via SNAIL-Dependent E-Cadherin Regulation
Koichi Ito et al.
CANCER RESEARCH (2016)
Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer
Tarah M. Regan Anderson et al.
CANCER RESEARCH (2016)
Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer
Priya S. Mathur et al.
MOLECULAR CANCER RESEARCH (2016)
SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins
Mi-Jeong Park et al.
MOLECULAR CELL (2016)
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
Aifu Lin et al.
NATURE CELL BIOLOGY (2016)
TNFα/IFNγ Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells
Ricci J. Haines et al.
PLOS ONE (2016)
Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways
Ippei Kikuchi et al.
NATURE COMMUNICATIONS (2016)
A boy with conduct disorder (CD), attention deficit hyperactivity disorder (ADHD), borderline intellectual disability, and 47, XXY syndrome in combination with a 7q11.23 duplication, 11p15.5 deletion, and 20q13.33 deletion
Gerasimos Kolaitis et al.
CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH (2016)
The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer
Xiao-Jing Wang et al.
CHINESE JOURNAL OF CANCER (2016)
Protein tyrosine kinase 6 mediates TNFα-induced endothelial barrier dysfunction
R. J. Haines et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition
Tiffany Tsui et al.
BIOCHEMISTRY (2015)
Novel 4-anilino-α-carboline derivatives induce cell death in nonadhesive breast cancer cells through inhibition of Brk activity
Markus Oelze et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase
Gaofeng Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin
Michael I. Chastkofsky et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions
Elisa Penna et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Brk/Protein Tyrosine Kinase 6 Phosphorylates p27KIP1, Regulating the Activity of Cyclin D-Cyclin-Dependent Kinase 4 (Publication with Expression of Concern. See vol. 42, 2022)
Priyank Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
PTK6 Potentiates Gemcitabine-Induced Apoptosis by Prolonging S-phase and Enhancing DNA Damage in Pancreatic Cancer
Hiroaki Ono et al.
MOLECULAR CANCER RESEARCH (2015)
Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse
M. Peng et al.
CELL DEATH & DISEASE (2015)
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
Timothy J. Stuhlmiller et al.
CELL REPORTS (2015)
Discovery, Optimization, and Pharmacophore Modeling of Oleanolic Acid and Analogues as Breast Cancer Cell Migration and Invasion Inhibitors Through Targeting Brk/Paxillin/Rac1 Axis
Heba E. Elsayed et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2, and PTK6-Mediated Cell Survival
Guoyu Yu et al.
MOLECULAR CANCER RESEARCH (2015)
Sphingosine-1-Phosphate Induces the Migration of Thyroid Follicular Carcinoma Cells through the MicroRNA-17/PTK6/ERK1/2 Pathway
Shitao Zhao et al.
PLOS ONE (2015)
PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2+ breast cancer cells by inducing Bim
Sun Hee Park et al.
BREAST CANCER RESEARCH (2015)
Discovery of 4-anilino α-carbolines as novel Brk inhibitors
Kazem Ahmed Mahmoud et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6
Hyun Jae Shim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
HIF-1 alpha-independent hypoxia-induced rapid PTK6 stabilization is associated with increased motility and invasion
Isabel M. Pires et al.
CANCER BIOLOGY & THERAPY (2014)
Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma
You-Fang Chen et al.
MEDICAL ONCOLOGY (2014)
Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling
Asmaa A. Sallam et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
Sayem Miah et al.
PLOS ONE (2014)
PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling
Hiroaki Ono et al.
PLOS ONE (2014)
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
Maoyu Peng et al.
ONCOTARGET (2014)
Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression
Tarah M. Regan Anderson et al.
CANCER RESEARCH (2013)
PTK6 Activation at the Membrane Regulates Epithelial-Mesenchymal Transition in Prostate Cancer
Yu Zheng et al.
CANCER RESEARCH (2013)
HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain
Midan Ai et al.
CELLULAR SIGNALLING (2013)
Optimization of Marine Triterpene Sipholenols as Inhibitors of Breast Cancer Migration and Invasion
Ahmed I. Foudah et al.
CHEMMEDCHEM (2013)
miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway
Hui Wang et al.
EUROPEAN JOURNAL OF CANCER (2013)
Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer
Yu Zheng et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK/PTK6 in Ovarian Cancer Cells
Gaofeng Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
Xue-Kui Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT
Y. Zheng et al.
ONCOGENE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling
Harina Vin et al.
ELIFE (2013)
Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
M. Peng et al.
ONCOGENESIS (2013)
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers
Nancy L. Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells
Shin-Ae Kang et al.
BIOCHEMICAL JOURNAL (2012)
Identification of PTK6, via RNA Sequencing Analysis, as a Suppressor of Esophageal Squamous Cell Carcinoma
Stephanie Ma et al.
GASTROENTEROLOGY (2012)
Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate
Yu Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting Protein Tyrosine Kinase 6 Enhances Apoptosis of Colon Cancer Cells following DNA Damage
Jessica J. Gierut et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR
X. Li et al.
ONCOGENE (2012)
Hwanggeumchal sorghum Induces Cell Cycle Arrest, and Suppresses Tumor Growth and Metastasis through Jak2/STAT Pathways in Breast Cancer Xenografts
Jin Hee Park et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression
Alessia Locatelli et al.
HORMONES & CANCER (2012)
Discovery of novel imidazo[1,2-a]pyrazin-8-amines as Brk/PTK6 inhibitors
Hongbo Zeng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells
Osamu Ikeda et al.
CANCER SCIENCE (2011)
X-Ray Crystal Structure of Bone Marrow Kinase in the X Chromosome: A Tec Family Kinase
Jodi Muckelbauer et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Disruption of the Mouse Protein Tyrosine Kinase 6 Gene Prevents STAT3 Activation and Confers Resistance to Azoxymethane
Jessica Gierut et al.
GASTROENTEROLOGY (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin
Patrick M. Brauer et al.
PLOS ONE (2011)
Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance
Chuifeng Fan et al.
TUMOR BIOLOGY (2011)
Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK
Kristopher A. Lofgren et al.
BREAST CANCER RESEARCH (2011)
Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells
Patrick M. Brauer et al.
CELL CYCLE (2010)
Brk/PTK6 signaling in normal and cancer cell models
Julie H. Ostrander et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells
Osamu Ikeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of β-catenin as a target of the intracellular tyrosine kinase PTK6
Helena L. Palka-Hamblin et al.
JOURNAL OF CELL SCIENCE (2010)
Comparative Analysis of Human Src-Family Kinase Substrate Specificity in Vitro
Hiroyuki Takeda et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Protein Tyrosine Kinase 6 Directly Phosphorylates AKT and Promotes AKT Activation in Response to Epidermal Growth Factor
Yu Zheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
Jiannong Li et al.
NATURE CHEMICAL BIOLOGY (2010)
PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival
Hanna Y. Irie et al.
PLOS ONE (2010)
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases
Douglas J. Marcotte et al.
PROTEIN SCIENCE (2010)
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells
Nancy E. Castro et al.
BREAST CANCER RESEARCH (2010)
Brk Protects Breast Cancer Cells from Autophagic Cell Death Induced by Loss of Anchorage
Amanda J. Harvey et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6
Sunggeon Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation
Osamu Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Jalview Version 2-a multiple sequence alignment editor and analysis workbench
Andrew M. Waterhouse et al.
BIOINFORMATICS (2009)
DOG 1.0: illustrator of protein domain structures
Jian Ren et al.
CELL RESEARCH (2009)
BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest
Kiven E. Lukong et al.
CELLULAR SIGNALLING (2009)
Induction of Protein Tyrosine Kinase 6 in Mouse Intestinal Crypt Epithelial Cells Promotes DNA Damage-Induced Apoptosis
Andrea Haegebarth et al.
GASTROENTEROLOGY (2009)
Oncogenic Functions of PTK6 are Enhanced by Its Targeting to Plasma Membrane But Abolished by Its Targeting to Nucleus
Han Ie Kim et al.
JOURNAL OF BIOCHEMISTRY (2009)
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
M. Aubele et al.
BRITISH JOURNAL OF CANCER (2008)
Breast tumor kinase phosphorylates p190RhoGAP to regulate Rho and Ras and promote breast carcinoma growth, migration, and invasion
Che-Hung Shen et al.
CANCER RESEARCH (2008)
Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms
Goutam Chakraborty et al.
CANCER RESEARCH (2008)
Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration
Kiven E. Lukong et al.
CELLULAR SIGNALLING (2008)
Solid-phase peptide library synthesis on HiCore resin for screening substrate specificity of Brk protein tyrosine kinase
Dong-Sik Shin et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2008)
Conditionally immortalized colonic epithelial cell line from a Ptk6 null mouse that polarizes and differentiates in vitro
Robert H. Whitehead et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Gene expansion and retention leads to a diverse tyrosine kinase superfamily in amphioxus
Salvatore D'Aniello et al.
MOLECULAR BIOLOGY AND EVOLUTION (2008)
BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells
Elisa Sala et al.
MOLECULAR CANCER RESEARCH (2008)
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Mohammad Azam et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Brk is coamplified with ErbB2 to promote proliferation in breast cancer
Bin Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Breast tumor kinase (Protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
Julie Hanson Ostrander et al.
CANCER RESEARCH (2007)
Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6
Amanda M. Weaver et al.
BREAST CANCER RESEARCH (2007)
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary
Rosemarie E. Schmandt et al.
CANCER BIOLOGY & THERAPY (2006)
Identification of STAT3 as a specific substrate of breast tumor kinase
L. Liu et al.
ONCOGENE (2006)
Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine
Andrea Haegebarth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants
John S. Tokarski et al.
CANCER RESEARCH (2006)
Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes
M Kasprzycka et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Tyrosine phosphorylation of Sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression
KE Lukong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis
A Haegebarth et al.
CELL CYCLE (2005)
Interaction between Brk kinase and insulin receptor substrate-4
HQ Qiu et al.
ONCOGENE (2005)
Role of breast tumour kinase in the in vitro differentiation of HaCaT cells
TC Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas
M Born et al.
JOURNAL OF PATHOLOGY (2005)
Role of the Brk SH3 domain in substrate recognition
HQ Qiu et al.
ONCOGENE (2004)
Identification of tyrosine kinases overexpressed in head and neck cancer
HS Lin et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2
A Haegebarth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain
EM Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Brk activates Rac1 and promotes cell migration and invasion by phosphorylating paxillin
HY Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium
BJ Petro et al.
ORAL ONCOLOGY (2004)
Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation
AJ Harvey et al.
ONCOGENE (2003)
Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells
JJ Derry et al.
ONCOGENE (2003)
Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis
C Zhao et al.
CANCER (2003)
Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK
JH Coyle et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition
HQ Qiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of the 5′-flanking region of the human PTK6 gene
KN Kang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Letter to the Editor:: Complete sequence-specific 1H, 13C and 15N resonance assignments of the human PTK6 SH2 domain
EM Hong et al.
JOURNAL OF BIOMOLECULAR NMR (2001)
Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation
T Kamalati et al.
ONCOGENE (2000)
A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK
PJ Mitchell et al.
ONCOGENE (2000)
Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability
JJ Derry et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
